Alkermes plc (ALKS) - Cekelan dhuwit saben saham

Lambang korporat lan logo Alkermes plc (ALKS)

Alkermes plc (ALKS) is protected by patents on complex injectable formulations, which limits generic expansion. A sufficient liquidity surplus allows the company to fund R&D without external borrowing. The cash per share metric visualizes this margin of safety, and its current level is 4.54. The chronic nature of psychiatric disorders guarantees the company a stable revenue stream from patients' continuous medication use.

Alkermes Inc. (ALKS) - Dana dhuwit saben saham saka 04.07.2022 nganti 20.11.2026

Rincian analitis perusahaan Alkermes plc

- rincian posisi dhuwit lan arus kas:
Analisis umum perusahaan:Alkermes Corp - ALKS
Produk asli Alkermes

This metric reflects the amount of free cash flow per common share, allowing for an assessment of the company's actual liquidity and internal reserves. For the biopharmaceutical business of Alkermes plc (ALKS), with its patent portfolio and royalties, an analysis of the issuer's cash per share via the GURU.Markets platform reveals a balance between R&D investments and operational efficiency, determining the fundamental stability of the business.